Geetika Arora Klevos, MD - Medicare Diagnostic Radiology in Pembroke Pines, FL

Geetika Arora Klevos, MD is a medicare enrolled "Radiology - Diagnostic Radiology" physician in Pembroke Pines, Florida. She graduated from medical school in 2001 and has 23 years of diverse experience with area of expertise as Diagnostic Radiology. She is a member of the group practice Vitalmd Group Holding Llc and her current practice location is 15735 Pines Blvd, Pembroke Pines, Florida. You can reach out to her office (for appointments etc.) via phone at (954) 517-1725.

Geetika Arora Klevos is licensed to practice in Florida (license number ME103295) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1164624789.

Contact Information

Geetika Arora Klevos, MD
15735 Pines Blvd,
Pembroke Pines, FL 33027-1207
(954) 517-1725
(954) 517-1729



Physician's Profile

Full NameGeetika Arora Klevos
GenderFemale
SpecialityDiagnostic Radiology
Experience23 Years
Location15735 Pines Blvd, Pembroke Pines, Florida
Accepts Medicare AssignmentsYes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Geetika Arora Klevos graduated from medical school in 2001
  NPI Data:
  • NPI Number: 1164624789
  • Provider Enumeration Date: 06/05/2007
  • Last Update Date: 02/19/2019
  Medicare PECOS Information:
  • PECOS PAC ID: 8022250315
  • Enrollment ID: I20130816000017

Medical Identifiers

Medical identifiers for Geetika Arora Klevos such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1164624789NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
2085R0202XRadiology - Diagnostic Radiology ME103295 (Florida)Primary

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Vitalmd Group Holding Llc8921091786428

News Archive

Bioheart initiates REGEN Phase I Clinical Trial for testing genetically modified MyoCell in CHF patients

Bioheart, Inc., announced today that the company has commenced work on its REGEN trial, a Phase I Clinical Trial to test genetically modified MyoCell® in patients suffering from Congestive Heart Failure (CHF). Bioheart's MyoCell® is a regenerative cell therapy that uses myoblasts, or muscle stem cells,that are grown from a patient's own muscle. MyoCell® has been tested successfully on patients in four clinical trials.

Magnesium sulfate has protective effect on maternal fever during labor

Women who received magnesium sulfate during labor were less likely to develop maternal fever, a condition that can lead to a variety of complications in newborns including difficulty breathing, seizures, cerebral palsy and a condition known as "floppy baby syndrome," characterized by inadequate muscle tone, according to a retrospective study presented at the ANESTHESIOLOGY 2015 annual meeting in San Diego.

American College of Physicians sends letter to House leaders voicing support for H.R. 3962 health bill

The American College of Physicians (ACP) today sent a letter to House leaders voicing the College's support for key policies in the Affordable Health Care for America Act.

HHS announces $60M to address barriers in adopting health IT

David Blumenthal, M.D., Department of Health and Human Services' (HHS) National Coordinator for Health Information Technology, today announced plans to make available $60 million to support the development of Strategic Health IT Advanced Research Projects (SHARP). SHARP projects will conduct focused research in critical areas where breakthrough advances are needed to address existing barriers to the adoption and meaningful use of health information technology (health IT).

AstraZeneca presents preliminary data from AZD6094-AZD9291 combination trial for treatment of NSCLC

Hutchison China MediTech Limited, today announces that AstraZeneca AB, Hutchison MediPharma Limited's collaboration partner, presented preliminary data from the ongoing Phase Ib clinical trial of HMP's c-Met inhibitor savolitinib (AZD6094) combined with AstraZeneca's drug candidate AZD9291 in non-small cell lung cancer.

Read more Medical News

› Verified 9 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Geetika Arora Klevos allows following entities to bill medicare on her behalf.
Entity NameVitalmd Group Holding Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1871572032
PECOS PAC ID: 8921091786
Enrollment ID: O20040406001878

News Archive

Bioheart initiates REGEN Phase I Clinical Trial for testing genetically modified MyoCell in CHF patients

Bioheart, Inc., announced today that the company has commenced work on its REGEN trial, a Phase I Clinical Trial to test genetically modified MyoCell® in patients suffering from Congestive Heart Failure (CHF). Bioheart's MyoCell® is a regenerative cell therapy that uses myoblasts, or muscle stem cells,that are grown from a patient's own muscle. MyoCell® has been tested successfully on patients in four clinical trials.

Magnesium sulfate has protective effect on maternal fever during labor

Women who received magnesium sulfate during labor were less likely to develop maternal fever, a condition that can lead to a variety of complications in newborns including difficulty breathing, seizures, cerebral palsy and a condition known as "floppy baby syndrome," characterized by inadequate muscle tone, according to a retrospective study presented at the ANESTHESIOLOGY 2015 annual meeting in San Diego.

American College of Physicians sends letter to House leaders voicing support for H.R. 3962 health bill

The American College of Physicians (ACP) today sent a letter to House leaders voicing the College's support for key policies in the Affordable Health Care for America Act.

HHS announces $60M to address barriers in adopting health IT

David Blumenthal, M.D., Department of Health and Human Services' (HHS) National Coordinator for Health Information Technology, today announced plans to make available $60 million to support the development of Strategic Health IT Advanced Research Projects (SHARP). SHARP projects will conduct focused research in critical areas where breakthrough advances are needed to address existing barriers to the adoption and meaningful use of health information technology (health IT).

AstraZeneca presents preliminary data from AZD6094-AZD9291 combination trial for treatment of NSCLC

Hutchison China MediTech Limited, today announces that AstraZeneca AB, Hutchison MediPharma Limited's collaboration partner, presented preliminary data from the ongoing Phase Ib clinical trial of HMP's c-Met inhibitor savolitinib (AZD6094) combined with AstraZeneca's drug candidate AZD9291 in non-small cell lung cancer.

Read more Medical News

› Verified 9 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Geetika Arora Klevos is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Geetika Arora Klevos, MD
15735 Pines Blvd,
Pembroke Pines, FL 33027-1207

Ph: (954) 517-1725
Geetika Arora Klevos, MD
15735 Pines Blvd,
Pembroke Pines, FL 33027-1207

Ph: (954) 517-1725

News Archive

Bioheart initiates REGEN Phase I Clinical Trial for testing genetically modified MyoCell in CHF patients

Bioheart, Inc., announced today that the company has commenced work on its REGEN trial, a Phase I Clinical Trial to test genetically modified MyoCell® in patients suffering from Congestive Heart Failure (CHF). Bioheart's MyoCell® is a regenerative cell therapy that uses myoblasts, or muscle stem cells,that are grown from a patient's own muscle. MyoCell® has been tested successfully on patients in four clinical trials.

Magnesium sulfate has protective effect on maternal fever during labor

Women who received magnesium sulfate during labor were less likely to develop maternal fever, a condition that can lead to a variety of complications in newborns including difficulty breathing, seizures, cerebral palsy and a condition known as "floppy baby syndrome," characterized by inadequate muscle tone, according to a retrospective study presented at the ANESTHESIOLOGY 2015 annual meeting in San Diego.

American College of Physicians sends letter to House leaders voicing support for H.R. 3962 health bill

The American College of Physicians (ACP) today sent a letter to House leaders voicing the College's support for key policies in the Affordable Health Care for America Act.

HHS announces $60M to address barriers in adopting health IT

David Blumenthal, M.D., Department of Health and Human Services' (HHS) National Coordinator for Health Information Technology, today announced plans to make available $60 million to support the development of Strategic Health IT Advanced Research Projects (SHARP). SHARP projects will conduct focused research in critical areas where breakthrough advances are needed to address existing barriers to the adoption and meaningful use of health information technology (health IT).

AstraZeneca presents preliminary data from AZD6094-AZD9291 combination trial for treatment of NSCLC

Hutchison China MediTech Limited, today announces that AstraZeneca AB, Hutchison MediPharma Limited's collaboration partner, presented preliminary data from the ongoing Phase Ib clinical trial of HMP's c-Met inhibitor savolitinib (AZD6094) combined with AstraZeneca's drug candidate AZD9291 in non-small cell lung cancer.

Read more News

› Verified 9 days ago


Radiology Doctors in Pembroke Pines, FL

Kyungmin Kang, M.D.
Radiology
Medicare: Accepting Medicare Assignments
Practice Location: 500 N Hiatus Rd Ste 200, Pembroke Pines, FL 33026
Phone: 954-437-4800    Fax: 954-437-6628
Dr. Howard T. Heller, MD
Radiology
Medicare: Medicare Enrolled
Practice Location: 9050 Pines Blvd Ste 200, Pembroke Pines, FL 33024
Phone: 954-437-4800    Fax: 954-437-6628
Elitsa Ivanova, MD
Radiology
Medicare: Accepting Medicare Assignments
Practice Location: Memorial Hospital West, 703 North Flamingo Road, Pembroke Pines, FL 33028
Phone: 954-844-7315    
Dr. Srinath Sundararaman, M.D.
Radiology
Medicare: Accepting Medicare Assignments
Practice Location: 500 N Hiatus Rd Ste 200, Pembroke Pines, FL 33026
Phone: 954-437-4800    
Matthew L Hoffman, M.D.
Radiology
Medicare: Accepting Medicare Assignments
Practice Location: Memorial Regional Pembroke, 7800 Sheridan Street, Pembroke Pines, FL 33024
Phone: 954-967-2051    
Dr. Hugh M Eisen, MD
Radiology
Medicare: Not Enrolled in Medicare
Practice Location: 15811 Sw 14th St, Pembroke Pines, FL 33027
Phone: 954-435-1730    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.